<http://webisa.webdatacommons.org/306387642>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/306387642>	<http://www.w3.org/ns/prov#value>	"The nano-construct of claim 10, wherein the targeting molecule is a surface-conjugated ligand against one or more receptors on an inflamed endothelium." .
<http://webisa.webdatacommons.org/prov/57648731>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/306387642> .
<http://webisa.webdatacommons.org/306387642>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.co.uk> .